Outcome of etoposide and mitoxantrone for relapsed or refractory acute myeloid leukemia (RR-AML) in the modern era.

被引：0
|
作者：
Bowman, Zelia Ramone Karema
Caddell, Ryan James
Kanate, Abraham Sebastian
Shillingburg, Alex
Shah, Nilay Arvind
Craig, Michael
Cumpston, Aaron
机构：
[1] West Virginia Univ, Robert C Byrd Hlth Sci Ctr, Morgantown, WV USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[3] West Virginia Univ, Morgantown, WV USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e18515
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18515
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Phase I/II study of escalating doses of mitoxantrone in a single injection combined with timed sequential therapy with cytarabine and etoposide in patients with refractory or relapsed acute myeloid leukemia (AML).
    Thomas, X
    Cambier, N
    Taksin, AL
    Reman, O
    Vekhoff, A
    Cordonnier, C
    Leblond, V
    Soler-Michel, P
    Ecstein-Fraïssé, E
    Archimbaud, E
    BLOOD, 1999, 94 (10) : 238B - 238B
  • [42] A multi-institutional comparison of mitoxantrone, etoposide, and cytarabine vs high-dose cytarabine and mitoxantrone therapy for patients with relapsed or refractory acute myeloid leukemia
    Christian, Sonia
    Arain, Saad
    Patel, Pritesh
    Khan, Irum
    Calip, Gregory S.
    Agrawal, Vaibhav
    Sweiss, Karen
    Griffin, Shawn
    Cahill, Kirk
    Konig, Heiko
    Esen, Aysenur
    Shergill, Ardaman
    Odenike, Olatoyosi
    Stock, Wendy
    Quigley, John G.
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (08) : 937 - 943
  • [43] Bortezomib plus MEC (Mitoxantrone, Etoposide, Cytarabine) for Relapsed/Refractory Acute Myeloid Leukemia: Final Results of an Expanded Phase 1 Trial
    Advani, Anjali S.
    Elson, Paul
    Kalaycio, Matt E.
    Mukherjee, Sudipto
    Gerds, Aaron T.
    Hamilton, Betty K.
    Hobson, Sean
    Smith, Arian
    Rush, Mary Lynn
    Bogati, Samjhana
    Biggins, Monique
    Hsi, Eric D.
    Duong, Hien K.
    Copelan, Edward A.
    Reu, Frederic J.
    Saunthararajah, Yogen
    Nazha, Aziz
    Makishima, Hideki
    Przychodzen, Bartlomiej
    Dienes, Brittney
    Maciejewski, Jaroslaw P.
    Carew, Jennifer S.
    Carraway, Hetty E.
    Sekeres, Mikkael A.
    BLOOD, 2014, 124 (21)
  • [44] A Phase 2 Study of Lenalidomide in Combination with Mitoxantrone, Etoposide, and Cytarabine (Len plus MEC) in Patients with Relapsed or Refractory Acute Myeloid Leukemia
    Kuchroo, Manik Razdan
    Redd, Robert A.
    Garcia, Jacqueline S.
    Keng, Michael
    Hobbs, Gabriela S.
    Rosenblatt, Jacalyn
    Luskin, Marlise R.
    Narayan, Rupa
    Amrein, Philip C.
    McMasters, Malgorzata
    Wadleigh, Martha
    Hock, Hanno
    Stone, Richard
    Neuberg, Donna S.
    Avigan, David
    Ballen, Karen K.
    Fathi, Amir T.
    DeAngelo, Daniel J.
    Brunner, Andrew M.
    BLOOD, 2023, 142
  • [45] Efficacy of mitoxantrone and etoposide in patients with acute myeloid leukemia refractory to initial standard induction therapy
    Sehgal, Rajesh
    McHayleh, Wassim
    Natale, James
    Raptis, Anastasios
    Agha, Mounzer
    Redner, Robert L.
    Richard, Gene
    Welsh, Ann
    Foon, Kenneth A.
    Boyiadzis, Michael
    BLOOD, 2007, 110 (11) : 164B - 164B
  • [46] Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia -: An Eastern Cooperative Oncology Group Pilot Study
    Tallman, MS
    Lee, S
    Sikic, BI
    Paietta, E
    Wiernik, PH
    Bennett, JM
    Rowe, JM
    CANCER, 1999, 85 (02) : 358 - 367
  • [47] MITOXANTRONE IN THE TREATMENT OF RELAPSED AND REFRACTORY ACUTE-LEUKEMIA
    EHNINGER, G
    HO, AD
    MEYER, P
    MJAALAND, I
    OSTENDORF, P
    SEITHER, E
    ONKOLOGIE, 1985, 8 (03): : 146 - 148
  • [48] IDARUBICIN, CYTOSINE-ARABINOSIDE AND ETOPOSIDE FOR RELAPSED OR REFRACTORY ACUTE MYELOID-LEUKEMIA
    HEIL, G
    BUNJES, D
    ARNOLD, R
    GOEBEL, M
    HEIMPEL, H
    KURRLE, E
    ONKOLOGIE, 1992, 15 (01): : 12 - 19
  • [49] MITOXANTRONE IN THE TREATMENT OF RELAPSED AND REFRACTORY ACUTE-LEUKEMIA
    MEYER, P
    HO, AD
    EHNINGER, G
    MJAALAND, I
    HEIDEMANN, E
    SEITHER, E
    INVESTIGATIONAL NEW DRUGS, 1985, 3 (02) : 203 - 206
  • [50] MITOXANTRONE IN THE TREATMENT OF RELAPSED AND REFRACTORY ACUTE-LEUKEMIA
    MOORE, JO
    OLSEN, GA
    SEMINARS IN ONCOLOGY, 1984, 11 (03) : 41 - 46
12345